Adverum Biotechnologies Inc. buy Truist Financial Co.
Start price
15.05.24
/
50%
€1.38
Target price
15.05.25
€55.13
Performance (%)
-
End price
16.05.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Adverum Biotechnologies Inc. | - | - | - |
| iShares Core DAX® | 1,01 % | 2,70 % | 4,36 % |
| iShares Nasdaq 100 | -6,47 % | -8,77 % | 18,00 % |
| iShares Nikkei 225® | -6,52 % | -12,58 % | 40,91 % |
| iShares S&P 500 | -2,72 % | -1,75 % | 16,97 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Adverum Biotechnologies Inc. diskutieren
Adverum Biotechnologies, Inc. (NASDAQ: ADVM) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $60.00 price target on the stock.
Ratings data for ADVM provided by MarketBeat
In the thread Trading Adverum Biotechnologies Inc.
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Truist_Financial_Co_ for Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.38
14.08.24
14.08.24
€36.26
14.08.25
14.08.25
-
15.08.25
15.08.25
Adverum Biotechnologies Inc.
Start price
Target price
Perf. (%)
€1.62
05.09.23
05.09.23
€5.60
05.09.24
05.09.24
-17.28%
06.09.24
06.09.24

